Bonnie Dirr, APRN, introduces a clinical scenario of a patient who received an allogeneic stem cell transplant from a sibling donor to begin the panel’s discussion of graft versus host disease.
Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy.
Drs Paczesny and Chen explain the importance of treating chronic GVHD as early as possible, and whether steroids are still the standard first-line treatment.